Daniel Herranz, PHARMD, PHD

Rutgers Cancer Institute – Assistant Professor of Pharmacology and Pediatrics

Dr. Herranz has pursued a combined training in metabolism and epigenetics and how both affect human cancer development through the generation and analysis of relevant mouse models. Dr. Herranz is an Assistant Professor in the Department of Pharmacology at the Robert Wood Johnson Medical School and a Resident Member at Rutgers Cancer Institute of New Jersey. Since 2017, he has established a highly successful and productive independent laboratory. His successful early career has been recognized by his being selected as a 2022 AACR NextGen Star and an LLS Scholar.

After his training in Pharmacy from the Complutense University of Madrid, Dr. Herranz completed a PhD in Molecular Biology and Biochemistry from the Autonomous University of Madrid under the supervision of Dr. Manuel Serrano at the Spanish National Cancer Research Center. Dr. Herranz then joined the laboratory of Adolfo Ferrando at Columbia University in April 2011 as a postdoctoral fellow.